Structure-Based Drug Design of Novel MARK-3 Inhibitors in Cancer

By  

Current Bioactive Compounds, Vol. 10, Iss. 2, 2014-07 ,pp. : 131-138

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Structure-Based Design of the Influenza A Neuraminidase Inhibitors

By  

Current Drug Targets, Vol. 11, Iss. 3, 2010-03 ,pp. : 315-326

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in Structure-Based Design of EGFR Inhibitors

By  

Current Drug Targets, Vol. 14, Iss. 7, 2013-06 ,pp. : 817-829

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based drug design for hypoxia-inducible factor prolyl-hydroxylase inhibitors and its therapeutic potential for the treatment of erythropoiesis-stimulating agent-resistant anemia: raising expectations for exploratory clinical trials

By Higashijima Yoshiki   Tanaka Tetsuhiro   Nangaku Masaomi  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 8, 2013-11 ,pp. : 965-976

Informa Healthcare

Access to resources Recommend Favorite

Discovery of HIV-1 Integrase Inhibitors through a Novel Combination of Ligand and Structure-based Drug Design

By  

Medicinal Chemistry, Vol. 1, Iss. 3, 2005-05 ,pp. : 263-275

Bentham Science Publishers

Access to resources Recommend Favorite